Songjiang Research Institute of Shanghai Jiao Tong University School of Medicine (hereinafter referred to as the Research Institute) was officially established on July 28, 2022. It is a scientific research institution jointly established by Shanghai Songjiang District People's Government and Shanghai Jiao Tong University School of Medicine. The first president is Academician Duan Shumin, and Professor Xu Tianle is the executive president. The Institute vigorously promotes institutional innovation, based on the research advantages of Shanghai Jiao Tong University School of Medicine - "Brain Science Research Alliance" in the fields of brain function and brain diseases, and takes the opportunity of undertaking the National Science and Technology Innovation 2030- "Brain Science and brain-like Research" major project and co-building Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (hereinafter referred to as Songjiang Hospital). Connecting with the "double first-class" construction of the School of Medicine of Shanghai Jiao Tong University and the "big health" strategy of the main campus of Shanghai Jiao Tong University; Continuously improve the interdisciplinary, cross-department and cross-industry interdisciplinary system and mechanism, effectively promote the cross-disciplinary, as well as the deep integration of brain science with basic medicine, clinical medicine and other advantageous disciplines, build a "talent chain, innovation chain, industrial chain", help Songjiang Hospital high-quality development, improve the level and level of regional medical services, and provide strong support for the construction of "healthy Songjiang".

Adhering to the concept of "talent is the first resource, innovation is the first driving force", the Institute has gathered a group of high-level talents with an international vision, and has recruited 22 outstanding PI at home and abroad to carry out research work. The high quality resources of the G60 Science and Innovation Corridor bio-medicine and brain-intelligence science and innovation industrial cluster are mainly focused on the "three brains" (developmental brain, mental brain, degenerative brain), combined with the emerging brain intersection directions of neuroimmunity, neurometabolism and neurotumor, and the institute building under construction will be completed by the end of 2024. In the future, it will build a 30,000 square meters "basic - clinical - industrial" full chain scientific research platform, which is committed to fostering the output of major innovative, original and subversive basic research results, achieving major breakthroughs in key technologies of original innovation, and cultivating a group of brain science professionals with innovative thinking and international influence. It will help the high-quality development of Shanghai's biomedicine and artificial intelligence industries, support the construction of "Healthy Shanghai" and "Healthy China" and the G60 science and technology innovation center with global influence, and become the source of brain science research and development in China and a new engine for the economic and social development of Songjiang District.

In the past two years, PI has published a series of papers in top international journals, including more than 10 papers in Science, Cell, Nature Neuroscience, Cell Stem Cell, Neuron, etc.